| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 1e-05 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.28 | 1e-05 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |